Search trends and survey data show where interest in weight loss drugs like Ozempic and Wegovy is surging in America.
Queen Latifah joins WeightWatchers as spokesperson for its new menopause program, part of the company’s post-relist strategy focused on women.
Evolv's oral GLP-1 supplement uses biomimetics to mimic the body’s natural satiety hormone and reduce appetite.
FuturHealth, a provider of weight-loss solutions including GLP-1s, will offer Apple Fitness+ at no additional cost to its members.
Noom’s microdose GLP-1 program says 70% of users report no side effects and lose up to 17 pounds in 60 days with behavior change support.
McKinsey’s latest report highlights a $5.65T opportunity in metabolic health. Here are five key takeaways for fitness and wellness brands.
In-Shape partners with Korb Health to offer GLP-1s, hormone therapy and more, merging fitness with clinical care.
At the ATN Summit, fitness leaders weighed how gyms can stay relevant in the GLP-1 era by focusing on accountability and long-term health.
Hims & Hers' Dr. Craig Primack explains why personalized care, not just GLP-1s, is the key to lasting weight loss success.
WeightWatchers partners with U.K.-based CheqUp to expand GLP-1 support, following news of its Chapter 11 and focus on long-term growth.
Sign Up to Our Newsletter
